Navigation Links
Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
Date:1/27/2011

e obtained at the SEC's website at www.sec.gov or from Roth Capital Partners, LLC by e-mail to rothecm@roth.com or by mail to 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, Pennsylvania 19422.

About Inovio Pharmaceuticals, Inc.Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include HPV/cervical dysplasia and cancer (therapeutic), avian flu (preventive), and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, National Microbiology Laboratory of the Public Health Agency of Canada, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)...  The need to add tissue preserving therapies ... prominently at the 108 th Annual Meeting ... Diego.  According to SonaCare Medical, a leader in ... the need for image-guided technologies to better identify ... minimally invasive ablative treatments, was addressed in the ...
(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... 24, 2011 Cadence, Inc., a leading manufacturer of ... markets, announced yesterday that it will invest nearly $16 ... allow Cadence to expand its capabilities in the medical ... significant new business. "This major expansion ...
... 2011 For the fifth straight year, Elekta has ... Clinical Oncology (ASCO) Electronic Health Records (EHR) Lab, June ... will be Elekta,s MOSAIQ® Oncology Information System, the first ... under the federal government,s HITECH Act. MOSAIQ is fully ...
Cached Medicine Technology:Cadence, Inc. Announces Major Expansion 2Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting 2
(Date:5/24/2013)... Toronto, ON (PRWEB) May 24, 2013 ... for hosted voice, video, data, and IT security ... ability to reduce communication costs by more than ... Via a Limited Time Hosted PBX Bundle Pricing. ... the nation in touch with VoIP. , Starting ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 Chronic ... illness that plagues sufferers with unexplained fatigue lasting 6 ... include short term memory and concentration impairment, muscle and ... tender lymph nodes, un-refreshing sleep and malaise that lasts ... obesity are now known to be linked to insulin ...
(Date:5/24/2013)... Today marks the launch of Destination Halifax’s ... , The redesigned and enhanced Itinerary Builder will help ... their computer or mobile device that they can send, ... users to fill in their date of arrival and ... choice of vacation packages, accommodations, restaurants, and things to ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Bridal ... pleased to announce new 2013 bridesmaid dresses ... 2013 bridesmaid dresses are handcrafted, featured as fine fabrics, ... wedding dress takes great skill and an eye for ... exquisite hand-made embroidery, brought to life from patterns and ...
(Date:5/24/2013)... UK (PRWEB) May 24, 2013 The leading ... 50% discount offer on short prom dresses . Now ... quality that is standard with the brand name since its ... collections in prom dresses. And now this huge discount offer ... , “I feel highly privileged to announce that ...
Breaking Medicine News(10 mins):Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2
... of veterinary medicine at Iowa State University, has identified ... disease, Immune-Mediated Retinopathy, or IMR, causes loss of function ... canines. , Grozdanic,s findings are published in the March ... Practice. , IMR is very similar to a previously ...
... March 4 Secretary of Health Dr.,Calvin B. ... Pediatric,Clinic in Warren to discuss Governor Edward G. ... to the hundreds of thousands of,uninsured adults through ... affordable insurance is critical to help prevent disease,successfully ...
... cancer risk in post-menopausal women after they stopped taking ... study that will be reported in the March 5 ... (JAMA), said Rowan T. Chlebowski, M.D., Ph.D., a Los ... contributed to the study. , This latest study reinforces ...
... 4 LeMaitre Vascular,Inc. (Nasdaq: LMAT ), a ... results for Q4 2007 and the year ended,December 31, ... of 27%,over Q4 2006. 2007 revenues were $41.4 million, ... increased 52% in the Company,s endovascular and,dialysis access category, ...
... the four ingredients in the genetic recipe that scientists in ... skin cells to revert to an embryonic stem cell state, ... a molecular alliance between a specific group of key proteins ... Genome Institute of Singapore (GIS) under the Agency for Science, ...
... therapy extended survival but not significantly , , TUESDAY, ... surgery for pancreatic cancer, adding the chemotherapy drug gemcitabine ... statistically significant, a new study finds. , Among patients ... a 50 percent to 85 percent rate of local ...
Cached Medicine News:Health News:Iowa State University researcher identifies eye disease in canines 2Health News:Health Secretary Stops in Warren County on Statewide Tour to Call for Action on Health Insurance for All Pennsylvanians 2Health News:LA BioMed researcher says 'unexpected' increase in cancer risk found 2Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 2Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 3Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 4Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 5Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 6Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 7Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 8Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 9Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 10Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 11Health News:LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase 12Health News:Molecular alliance that sustains embryonic stem cell state 2Health News:Molecular alliance that sustains embryonic stem cell state 3Health News:Treatment Combo for Pancreatic Cancer Has Limited Benefit 2
... Multifunctional instrumentation, capable of comminution, ... by means of ultra-sonic energy. ... organs, and, in particular, parenchymatous ... of tissue-selection and non-traumatic preparation ...
... system is the recognized world leader, ... superior tactile feedback and exceptional visualization ... surgical modality combines tissue fragmentation, irrigation, ... performance in procedures requiring precise, selective ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 7.5 mm....
Medicine Products: